We could say, for example, that KPVs antimicrobial benefits take effect within two hours (as in the study from 2000),15 but in real-world use, the treatment itself would take place across a longer timeline whose exact length can vary from person to person, case to case
First, the post incorrectly implies that the risk is mainly due to rapid intravenous administration of methylcobalamin itself, whereas the actual mechanism is related to marrow response after correction of severe deficiency
The foremost limitation is the absence of large-scale, randomized, and well-controlled clinical trials capable of establishing definitive evidence of safety and efficacy in human populations
Much of the published work on it comes from animal and lab studies, not from large human trials
The Wolverine Stack, BPC-157 and TB-500, goes beyond rest and ice